The neuropathobiology of multiple sclerosis
The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30470-2 · Cited by 8,167 · cited 1×
“Notably, magnetic resonance imaging (MRI) has become the most important tool in diagnosing MS because it can reveal the characteristic focal white matter lesions with specific spatial and temporal patterns indicative of the disease 10 .”
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · cited 1×
“prominently necroptosis and ferroptosis, leading to neuronal loss and disability progression.”
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293 · cited 1×
“prominently necroptosis and ferroptosis, leading to neuronal loss and disability progression.”
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734 · cited 1×
“Epigenetic mechanisms control acute and long-term gene-expression dynamics and shape cellular adaptation to environmental challenges and external cues 118 .”
Mechanisms, regulation and functions of the unfolded protein response
Hetz, C., Zhang, K., & Kaufman, R. J. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0250-z · Cited by 2,666
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491
Targeting Ferroptosis as a Vulnerability in Cancer
Lei, G., Zhuang, L., & Gan, B. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00459-0 · Cited by 2,252 · cited 1×
“A method that allows the analysis of chromatin accessibility by sequencing of open chromatin that was tagged and fragmented by the hyperactive transposase Tn5.”
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Self-citationBjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., et al. (2022) · Science · doi:10.1126/science.abj8222 · Cited by 2,049 · cited 1×
“Additionally, in a smaller cohort of individuals with Epstein–Barr virus (EBV) seroconversion, who are at higher risk of developing MS, NfL levels were found to be increased up to 2 years before MS was diagnosed 49 .”
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Montalban, X., Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Comi, G., de Seze, J., Giovannoni, G., Hartung, H.-P., Hemmer, B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606468 · Cited by 1,905 · cited 1×
“Ocrelizumab, a monoclonal antibody targeting CD20 and depleting antigen-presenting B cells, was the first drug to reach its clinical primary end point in a phase III study used in progressive MS to slow down clinical disability 57 .”
Cited by
Cell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesions
Lerma-Martin, C., Badia-i-Mompel, P., Ramirez Flores, R. O., Sekol, P., Schäfer, P. S. L., Riedl, C. J., Hofmann, A., Thäwel, T., Wünnemann, F., Ibarra-Arellano, M. A., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01796-z · Cited by 76
“It is known that mitochondrial dysfunction and metabolic exhaustion are known features of chronic MS lesions and have also been reported for reactive AS in MS 57,58 .”
The role of the adaptive immune system in the initiation and persistence of multiple sclerosis
Afzali, A. M., & Korn, T. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101947 · Cited by 25
Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis
Simões-Abade, M. B. C., Patterer, M., Nicaise, A. M., & Pluchino, S. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1488691 · Cited by 14
From insights to innovations: evaluating preclinical paradigms in demyelinating disease therapeutics
Karbalaee, M., Lin, A., Peruzzotti-Jametti, L., Pluchino, S., & Mozafari, S. (2026) · Lab Animal · doi:10.1038/s41684-026-01725-6 · Cited by 2
“…the initial trigger, demyelination disrupts axonal saltatory conduction, leading to ionic imbalances, excitotoxicity and impaired nerve signaling, ultimately resulting in axonal damage driven and maintained by neuroimmune activation, loss of glial support, metabolic stress and oxidative injury 28 .”
Insights and challenges on animal models for progressive multiple sclerosis
Nalepa, I. F., Haahr, N. O., Bekiaris, V., Jakobsen, M. R., Asuni, A. A., & Benmamar-Badel, A. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03805-3 · Cited by 1
“More detailed and extensive reviews of both innate as well as adaptive immune cells in PMS have been published elsewhere [59, 73–75].”
Metadata
- Authors
- Woo, M. S., Engler, J. B., & Friese, M. A.
- Venue
- Nature Reviews Neuroscience
- Published
- 2024-05-24
- Volume
- 25
- Issue
- 7
- Pages
- 493-513
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W4398775671
- Cited by
- 175
- References
- 82
- FWCI
- 21.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The neuropathobiology of multiple sclerosis. https://app.cochat.ai/papers/10.1038/s41583-024-00823-z
- The paper
- Woo, M. S., Engler, J. B., & Friese, M. A. (2024). The neuropathobiology of multiple sclerosis. Nature Reviews Neuroscience. https://doi.org/10.1038/s41583-024-00823-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.